PHVS
Pharvaris BV
31.20$
+0.6%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | -2.8% | – | – | – | – | – | – | – | +71.2% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.4% | -0.5% | +24.6% | +11.8% | +21.0% | -0.9% | -4.2% | +0.7% | +14.5% | -10.2% | +14.2% | – | |
| – | +11.8% | +14.4% | +15.5% | +7.1% | +14.6% | -18.9% | -4.5% | -8.5% | +36.6% | +0.0% | +17.3% | – | |
| – | +3.7% | +4.2% | +21.4% | +10.2% | +19.0% | -193.6% | – | -1.8% | +20.0% | -5.7% | +13.1% | – | |
| – | – | – | – | – | – | – | -195.7% | – | – | – | – | – | |
| – | – | – | +44,204.4% | -99.6% | – | – | – | – | – | – | -16.0% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | -75.2% | +225.8% | – | – | -33.0% | -189.5% | – | – | +116.9% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.